"Russia is an important market for us and we are consistently looking to expand product offerings. We believe OTC is an interesting space and this approval for Momate Rhino nasal spray will help enhance our presence in this segment," Glenmark Pharmaceuticals Senior Vice President and Head Asia, Russia CIS region Csaba Kantor said.from Moneycontrol Business News http://bit.ly/2IVvdm2
No comments:
Post a Comment